These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5167175)

  • 1. The inhibition of pyruvate decarboxylation in rat brain by -ketoisocaproic acid.
    Bowden JA; McArthur CL; Fried M
    Biochem Med; 1971 Apr; 5(2):101-8. PubMed ID: 5167175
    [No Abstract]   [Full Text] [Related]  

  • 2. -Ketoisocaproic acid inhibition of pyruvate and -ketoglutarate oxidative decarboxylation in rat liver slices.
    Bowden JA; Brestel EP; Cope WT; McArthur CL; Westfall DN; Fried M
    Biochem Med; 1970 Aug; 4(1):69-76. PubMed ID: 5524061
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of mitochondrial pyruvate transport by phenylpyruvate and alpha-ketoisocaproate.
    Halestrap AP; Brand MD; Denton RM
    Biochim Biophys Acta; 1974 Oct; 367(1):102-8. PubMed ID: 4418160
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of alpha-oxoglutarate and pyruvate oxidation by alpha-oxoderivatives of leucine and valine in rat tissues.
    Lysiak W; Stepiński J; Angielski S
    Acta Biochim Pol; 1970; 17(2):131-41. PubMed ID: 5530500
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of acetylcholine synthesis and of carbohydrate utilization by maple-syrup-urine disease metabolites.
    Gibson GE; Blass JP
    J Neurochem; 1976 Jun; 26(6):1073-8. PubMed ID: 945329
    [No Abstract]   [Full Text] [Related]  

  • 6. alpha-Ketoisocaproate stimulates malate-dependent pyruvate formation in rat heart mitochondria.
    Quattrochi LC; Hall LM; Becker GL
    Biochem Biophys Res Commun; 1982 Dec; 109(3):950-7. PubMed ID: 7159451
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of the branched-chain alpha-keto acids on pyruvate metabolism by homogenates of human brain.
    Patel MS; Auerbach VH; Grover WD; Wilbur DO
    J Neurochem; 1973 Jun; 20(6):1793-6. PubMed ID: 4719322
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition, by 2-oxo acids that accumulate in maple-syrup-urine disease, of lactate, pyruvate, and 3-hydroxybutyrate transport across the blood-brain barrier.
    Cremer JE; Teal HM; Cunningham VJ
    J Neurochem; 1982 Sep; 39(3):674-7. PubMed ID: 7201506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of pyruvate and beta-hydroxybutyrate oxidation in rat brain mitochondria by phenylpyruvate and alpha-ketoisocaproate.
    Land JM; Clark JB
    FEBS Lett; 1974 Aug; 44(3):348-51. PubMed ID: 4413896
    [No Abstract]   [Full Text] [Related]  

  • 10. Further observations on the biochemical lesion in maple syrup urine disease.
    Dreyfus PM; Prensky AL
    Nature; 1967 Apr; 214(5085):276. PubMed ID: 6034241
    [No Abstract]   [Full Text] [Related]  

  • 11. Chloride-dependent inhibition of vesicular glutamate uptake by alpha-keto acids accumulated in maple syrup urine disease.
    Reis M; Farage M; Wolosker H
    Biochim Biophys Acta; 2000 Jul; 1475(2):114-8. PubMed ID: 10832024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by the branched-chain 2-oxo acids of the 2-oxoglutarate dehydrogenase complex in developing rat and human brain.
    Patel MS
    Biochem J; 1974 Oct; 144(1):91-7. PubMed ID: 4462577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease.
    Sgaravatti AM; Rosa RB; Schuck PF; Ribeiro CA; Wannmacher CM; Wyse AT; Dutra-Filho CS; Wajner M
    Biochim Biophys Acta; 2003 Nov; 1639(3):232-8. PubMed ID: 14636955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease.
    Tavares RG; Santos CE; Tasca CI; Wajner M; Souza DO; Dutra-Filho CS
    J Neurol Sci; 2000 Dec; 181(1-2):44-9. PubMed ID: 11099711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maple syrup urine disease: analysis of branched chain ketoacid decarboxylation in cultured fibroblasts.
    Wendel U; Wentrup H; Rüdiger HW
    Pediatr Res; 1975 Sep; 9(9):709-17. PubMed ID: 1202420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transaminations between amino acids and keto acids elevated in phenylketonuria and maple syrup urine disease.
    Lees GJ; Weiner N
    J Neurochem; 1973 Feb; 20(2):389-403. PubMed ID: 4698286
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolongation of G1 and S phase in C-6 glioma cells treated with maple syrup urine disease metabolits. Morphologic and cell cycle studies.
    Liao CL; Herman MM; Bensch KG
    Lab Invest; 1978 Feb; 38(2):122-33. PubMed ID: 564423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on maple syrup disease in 2 families].
    Goedde HW; Richter E; Hüfner M; zur Mühlen A von
    Humangenetik; 1964; 1(2):163-9. PubMed ID: 5869967
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of alanine and aspartate aminotransferases by alpha-oxoderivatives of the branched-chain amino acids.
    Lysiak W; Pieńkowska-Vogel M; Szutowicz A; Angielski SA
    J Neurochem; 1974 Jan; 22(1):77-83. PubMed ID: 4818874
    [No Abstract]   [Full Text] [Related]  

  • 20. Branched chain alpha-keto acid metabolism. I. Isolation, purification, and partial characterization of bovine liver alpha-ketoisocaproic:alpha-keto-beta-methylvaleric acid dehydrogenase.
    Connelly JL; Danner DJ; Bowden JA
    J Biol Chem; 1968 Mar; 243(6):1198-203. PubMed ID: 5689906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.